Treatment of polymyalgia rheumatica and giant cell arteritis: are we any further forward?

Editorial

Raashid Luqmani. Ann Intern Med. 2007.

. 2007 May 1;146(9):674-6.

doi: 10.7326/0003-4819-146-9-200705010-00011.

No abstract available

Comment in

Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritis.
Salvarani C, Hunder GG. Salvarani C, et al. Ann Intern Med. 2008 Jan 15;148(2):167-8; author reply 168. doi: 10.7326/0003-4819-148-2-200801150-00018. Ann Intern Med. 2008. PMID: 18195345 No abstract available.

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group. Hoffman GS, et al. Ann Intern Med. 2007 May 1;146(9):621-30. doi: 10.7326/0003-4819-146-9-200705010-00004. Ann Intern Med. 2007. PMID: 17470830 Clinical Trial.
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG. Salvarani C, et al. Ann Intern Med. 2007 May 1;146(9):631-9. doi: 10.7326/0003-4819-146-9-200705010-00005. Ann Intern Med. 2007. PMID: 17470831 Clinical Trial.